European Committee gives green light to use self replicating vaccines on citizens of EU countries
🇪🇺European Committee gives green light to use self-replicating vaccines on citizens of EU countries
The Committee for Medicinal Products for Human Use has recommended marketing authorisation for Kostaive, a self-replicating mRNA (“saRNA”) injection developed by Arcturus Therapeutics. The final decision for regulatory approval now rests with the European Commission.
The European Commission must reject authorisation for these dangerous saRNA (replicon) vaccines.
Japan had already approved these injections last year. In November 2023, Japan’s Ministry of Health, Labor and Welfare (MHLW) fully approved CSL and Arcturus Therapeutics’ replicon shot, Kostaive ARCT-154. Despite enormous safety concerns, Japan’s MHLW approved the updated booster shot in September 2024 to target the JN.1 lineage of Omicron subvariants.
During the clinical trials for Kostaive, five deaths were reported among participants in the phase 3b study. Across study phases 1, 2, and 3a combined, 90% of injected participants experienced adverse events, with 74.5% reporting systemic reactions and 15.2% requiring medical attention after the first dose. Notably, many of the study authors are full-time employees of Arcturus Therapeutics, raising concerns about bias in their conclusions.
Source: https://notonthebeeb.co.uk/post/c19-self-amplifying-mrna-injection-nears-european-approval
Von Der Leyen 2024 “I’m pleased to pledge $290M for Gavi, the vaccine alliance. Together with Gavi, we have the goal to vaccinate 500M children by 2030…”
The Committee for Medicinal Products for Human Use has recommended marketing authorisation for Kostaive, a self-replicating mRNA (“saRNA”) injection developed by Arcturus Therapeutics. The final decision for regulatory approval now rests with the European Commission.
The European Commission must reject authorisation for these dangerous saRNA (replicon) vaccines.
Japan had already approved these injections last year. In November 2023, Japan’s Ministry of Health, Labor and Welfare (MHLW) fully approved CSL and Arcturus Therapeutics’ replicon shot, Kostaive ARCT-154. Despite enormous safety concerns, Japan’s MHLW approved the updated booster shot in September 2024 to target the JN.1 lineage of Omicron subvariants.
During the clinical trials for Kostaive, five deaths were reported among participants in the phase 3b study. Across study phases 1, 2, and 3a combined, 90% of injected participants experienced adverse events, with 74.5% reporting systemic reactions and 15.2% requiring medical attention after the first dose. Notably, many of the study authors are full-time employees of Arcturus Therapeutics, raising concerns about bias in their conclusions.
Source: https://notonthebeeb.co.uk/post/c19-self-amplifying-mrna-injection-nears-european-approval
Von Der Leyen 2024 “I’m pleased to pledge $290M for Gavi, the vaccine alliance. Together with Gavi, we have the goal to vaccinate 500M children by 2030…”
URL:
Uploaded by #39810
